(Q45866729)

17 December 2017

title

Immune responses to AAV capsid: are mice not humans after all? (English)

1 reference

17 December 2017

author name string

Roland W Herzog

series ordinal

1

1 reference

17 December 2017

publication date

1 April 2007

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

649-650

1 reference

17 December 2017

Adeno-associated virus serotypes: vector toolkit for human gene therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

730. T Cell Responses to AAV Vector Capsid in Normal Donors and Subjects Who Have Undergone Liver-Directed AAV-Mediated Gene Transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Identification of mouse AAV capsid-specific CD8+ T cell epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300123

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300123

1 reference

17 December 2017

PubMed ID

17372595

1 reference

17 December 2017